ArticleJournal of Cancer2017

Histone Deacetylase Inhibitor SAHA as Potential Targeted Therapy Agent for Larynx Cancer Cells.

Aneta Grabarska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.